DJIA 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%

11.07 0.09 (0.82%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OSIR $11.07 0.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.84
Previous Close $10.98
Daily Range $10.37 - $11.08
52-Week Range $5.51 - $14.46
Market Cap $364.6M
P/E Ratio -28.89
Dividend (Yield) $0.00 (0.0%)
Volume 78,794
Average Daily Volume 105,045
Current FY EPS -$0.31

Sector

Healthcare

Industry

Drugs

Osiris Therapeutics, Inc. (OSIR) Description

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas. Website: http://www.osiristx.com/

News & Commentary Rss Feed

Pipeline Progress at Gilead - Analyst Blog

Is the Golden Age of Blockbusters Over?

Big Pharma enjoyed a pretty historic run in the last two decades. But with the patent cliff stifling industry growth, is the Golden Age of the Blockbuster over for good? This one might be, but investors cannot rule out future opportunities.

Osiris Loss In-Line with Expectations - Analyst Blog

Osiris Therapeutics Management Discusses Q1 2013 Results - Earnings Call Transcript

Osiris CEO: Our Stem Cell Drug With Zero Sales Is Widely Used

Osiris Therapeutics Announces First Quarter 2013 Financial Results

Loss at Aegerion Narrower Than Expected - Analyst Blog

Affymetrix Reports Disappointing 1Q - Analyst Blog

Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog

Stem Cells: Invest At Your Own Peril

See More OSIR News...

OSIR's Top Competitors

OSIR $11.07 (0.82%)
Current stock: OSIR
AMGN $105.62 (1.04%)
Current stock: AMGN
GILD $55.48 (-0.80%)
Current stock: GILD
BIIB $232.62 (-0.19%)
Current stock: BIIB